These data suggested that an elevated level of ALKBH5 promoted an aggressive behavior, indicating that the molecule can be a novel prognostic biomarker and a therapeutic target for the treatment of epithelial ovarian cancer. The gene discussed is ALKBH5; the disease is ovarian carcinoma.